Stay Connected
Join us on Facebook Follow us on Twitter Follow us on linked in Follow us on YouTube
Drug Development in Alzheimer’s Disease Challenges and Opportunities

Samer Kaba, MD
Vice-President, Medical Affairs

Dr. Kaba has extensive experience in neurology, psychiatry, and analgesia drug development. He is a board-certified neurologist with additional training in neuro-immunology (MS) and neuro-oncology. He currently serves as a Clinical Assistant Professor of Neurology at Emory University, and is an active member of the American Academy of Neurology, Society for Neuro-Oncology, and American Society of Clinical Oncology. Dr. Kaba has authored many scientific publications and book chapters.

Additional Information

Leveraging decades of Phase I-IV experience in multiple therapeutic areas of drug development and our deep understanding of how to accelerate your drug towards approval, our therapeutic and regulatory experts excel at streamlining your trial process and delivering solutions focused on the critical needs of your study.